Examining the Effectiveness of a Connective Tissue Matrix Implant in Reducing Post-operative Pain and Narcotic After Outpatient Arthroscopic Shoulder Surgery
Stopped early · Not applicable
Conditions studied: Arthroscopic Shoulder Surgery, Pain, Postoperative
In brief
This document is a protocol for a human research study. This study is to be conducted according to United States standards of Good Clinical Practice in accordance with applicable Federal regulations and institutional research policies and procedures. Extracellular matrix grafts have been used to help with postoperative inflammation.
Key facts
- Study ID
- NCT04633837
- Run by
- Brian Badman
- People needed
- 15
- Starts
- 2020-12-04
- Expected to finish
- 2021-11-07
- Last updated by the study team
- 2022-01-06
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age 18 and older
- Primary diagnosis of rotator cuff tear, labral tear or SLAP tear
- Able to provide informed consent
- Is willing and able to accept text messages
You may not qualify if…
- Older than 55 years old.
- Pregnancy.
- Known narcotic or alcohol abuse (< 3 months)
- Revision shoulder surgery
- Current narcotic regimen or contract with pain management specialist
Where it is running
- American Health Network — Avon, Indiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.